|Day's range||169.97 - 169.98|
|52-week range||150.50 - 179.47|
|PE ratio (TTM)||N/A|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|
Linde AG and Praxair Inc. are considering selling assets to preempt regulators’ concerns about their merger, drawing interest from bidders including CVC Capital Partners and Advent International, people ...
Linde AG's Lincare unit has agreed to pay $20 million to resolve a whistleblower lawsuit accusing the company of fraudulently billing the U.S. government for oxygen and respiratory care equipment. The accord, confirmed by the U.S. Attorney's Office in Massachusetts, will resolve a lawsuit filed under the False Claims Act by former employees of the respiratory therapy services provider on behalf of the U.S. government.
German industrial gases group Linde will terminate its American depository receipt programme on Sept. 29 due to its planned $74 billion merger with U.S. peer Praxair, it said on Friday. "ADRs are not subject to the public offer to exchange Linde shares for shares in the new holding company, therefore ADR holders must exchange their ADRs for Linde shares in order to participate in the exchange offer," it said. Linde and Praxair plan to list shares in the new combined company in both New York and Frankfurt.